Fisher Asset Management
PPH icon

Fisher Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Fisher Asset Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
14,624
-524
-3% -$54.2K ﹤0.01% 636
2026
Q1 		$1.57M Sell
15,148
-318
-2% -$33.9K ﹤0.01% 620
2025
Q4 		$1.6M Sell
15,466
-1,069
-6% -$104K ﹤0.01% 596
2025
Q3 		$1.49M Buy
16,535
+1,534
+10% +$134K ﹤0.01% 628
2025
Q2 		$1.32M Sell
15,001
-1,263,699
-99% -$110M ﹤0.01% 643
2025
Q1 		$117M Buy
+1,278,700
New +$115M 0.05% 148

Other funds holding PPH

JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
RBC
Rye Brook Capital Greenwich, Connecticut $143M AUM 33.65% 1-Year Est. Return
WWM
WT Wealth Management Scottsdale, Arizona $361M AUM 23.03% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return

Fisher Asset Management's PPH Position: Q2 2026 in Review

Fisher Asset Management reduced its VanEck Pharmaceutical ETF (PPH) stake by 3.5% in Q2 2026, selling an estimated $54.2K and leaving 14,624 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #636.

Fisher Asset Management first reported a position in PPH in Q1 2025 and has held it in 6 quarters since. The position peaked at $117M in Q1 2025. 75 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Fisher Asset Management held 14,624 shares of VanEck Pharmaceutical ETF worth $1.6M as of Q2 2026.
  • Fisher Asset Management sold 524 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $54.2K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #636 holding.
  • Fisher Asset Management first reported a position in VanEck Pharmaceutical ETF in Q1 2025 and has held it in 6 quarters since.
  • Fisher Asset Management's VanEck Pharmaceutical ETF position peaked at $117M in Q1 2025.
  • 75 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.